FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2579159570> ?p ?o ?g. }

• W2579159570 endingPage "240" @default.
• W2579159570 startingPage "235" @default.
• W2579159570 abstract "Background: Antivenom has been successfully used to treat systemic and progressive, local manifestations of envenomation inflicted by Vipera (V.) palaestinae, the most common venomous snake in Israel. The objective of this study was to evaluate the fixed dose V. palaestinae monovalent (equine) immunoglobulin G antivenom used in two pediatric emergency departments. In particular, we wanted to assess the need for repeated antivenom administration and the rate of adverse antivenom effects in children.Methods: A retrospective chart review was performed for all children admitted with definite or probable signs of V. palaestinae envenomation to Chaim Sheba Medical Center and Kaplan Medical Center between 1 March 2008 and 1 March 2014. Extracted data included: age, location of bite, time to hospital arrival, time to antivenom administration if indicated, outcomes, and complications of the envenomation and adverse effects to the antivenom.Results: 57 patients met inclusion criteria; they ranged from 1 to 17 years in age and median age was 9.5 years. Clinical manifestations were evident in 55 (96.4%) of victims: 18 presented with minimal local signs and 37 showed marked progressive, local features (rapidly progressing edema) and signs of systemic envenomation: tachycardia (20), vomiting (17), abdominal pain (11) and hypotension (6). Two patients developed compartment syndrome and underwent surgical decompression (both received only a loading dose of antivenom with no subsequent maintenance dose). One patient developed thrombocytopenia and three patients presented with mild coagulopathy. Antivenom was administered to 25 (42%) children. Indications for antivenom administration included moderate to severe local signs (19 patients) and systemic signs (6 patients). None of these patients developed adverse reactions, serum sickness, or other side effects to the antivenom. One patient received a single additional 30mL dose of antivenom, due to hypotension and syncope, with good response.Conclusions: In children, 50 ml dosing of V. palaestinae antivenom is efficacious and safe for the treatment of systemic and progressive local manifestations of envenomation by V. palaestinae." @default.
• W2579159570 created "2017-01-26" @default.
• W2579159570 creator A5013014545 @default.
• W2579159570 creator A5015914937 @default.
• W2579159570 creator A5040706142 @default.
• W2579159570 creator A5045049429 @default.
• W2579159570 creator A5051185675 @default.
• W2579159570 creator A5056372543 @default.
• W2579159570 creator A5070678433 @default.
• W2579159570 creator A5084014236 @default.
• W2579159570 date "2017-01-20" @default.
• W2579159570 modified "2023-10-04" @default.
• W2579159570 title "Evaluation of antivenom therapy for <i>Vipera palaestinae</i> bites in children: experience of two large, tertiary care pediatric hospitals" @default.
• W2579159570 cites W1974158551 @default.
• W2579159570 cites W1989867208 @default.
• W2579159570 cites W1998807227 @default.
• W2579159570 cites W2010859979 @default.
• W2579159570 cites W2012220123 @default.
• W2579159570 cites W2032791411 @default.
• W2579159570 cites W2035763245 @default.
• W2579159570 cites W2036663974 @default.
• W2579159570 cites W2061668549 @default.
• W2579159570 cites W2079118007 @default.
• W2579159570 cites W2108738255 @default.
• W2579159570 cites W2118396482 @default.
• W2579159570 cites W2122870421 @default.
• W2579159570 cites W2150501383 @default.
• W2579159570 cites W2159987034 @default.
• W2579159570 cites W2163562702 @default.
• W2579159570 cites W2176199166 @default.
• W2579159570 doi "https://doi.org/10.1080/15563650.2016.1277233" @default.
• W2579159570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28103732" @default.
• W2579159570 hasPublicationYear "2017" @default.
• W2579159570 type Work @default.
• W2579159570 sameAs 2579159570 @default.
• W2579159570 citedByCount "14" @default.
• W2579159570 countsByYear W25791595702018 @default.
• W2579159570 countsByYear W25791595702019 @default.
• W2579159570 countsByYear W25791595702020 @default.
• W2579159570 countsByYear W25791595702021 @default.
• W2579159570 countsByYear W25791595702022 @default.
• W2579159570 crossrefType "journal-article" @default.
• W2579159570 hasAuthorship W2579159570A5013014545 @default.
• W2579159570 hasAuthorship W2579159570A5015914937 @default.
• W2579159570 hasAuthorship W2579159570A5040706142 @default.
• W2579159570 hasAuthorship W2579159570A5045049429 @default.
• W2579159570 hasAuthorship W2579159570A5051185675 @default.
• W2579159570 hasAuthorship W2579159570A5056372543 @default.
• W2579159570 hasAuthorship W2579159570A5070678433 @default.
• W2579159570 hasAuthorship W2579159570A5084014236 @default.
• W2579159570 hasConcept C117287731 @default.
• W2579159570 hasConcept C126322002 @default.
• W2579159570 hasConcept C141071460 @default.
• W2579159570 hasConcept C145600735 @default.
• W2579159570 hasConcept C159654299 @default.
• W2579159570 hasConcept C187212893 @default.
• W2579159570 hasConcept C18903297 @default.
• W2579159570 hasConcept C197934379 @default.
• W2579159570 hasConcept C203014093 @default.
• W2579159570 hasConcept C2779448229 @default.
• W2579159570 hasConcept C2779703309 @default.
• W2579159570 hasConcept C2780852908 @default.
• W2579159570 hasConcept C42219234 @default.
• W2579159570 hasConcept C71924100 @default.
• W2579159570 hasConcept C86803240 @default.
• W2579159570 hasConceptScore W2579159570C117287731 @default.
• W2579159570 hasConceptScore W2579159570C126322002 @default.
• W2579159570 hasConceptScore W2579159570C141071460 @default.
• W2579159570 hasConceptScore W2579159570C145600735 @default.
• W2579159570 hasConceptScore W2579159570C159654299 @default.
• W2579159570 hasConceptScore W2579159570C187212893 @default.
• W2579159570 hasConceptScore W2579159570C18903297 @default.
• W2579159570 hasConceptScore W2579159570C197934379 @default.
• W2579159570 hasConceptScore W2579159570C203014093 @default.
• W2579159570 hasConceptScore W2579159570C2779448229 @default.
• W2579159570 hasConceptScore W2579159570C2779703309 @default.
• W2579159570 hasConceptScore W2579159570C2780852908 @default.
• W2579159570 hasConceptScore W2579159570C42219234 @default.
• W2579159570 hasConceptScore W2579159570C71924100 @default.
• W2579159570 hasConceptScore W2579159570C86803240 @default.
• W2579159570 hasIssue "4" @default.
• W2579159570 hasLocation W25791595701 @default.
• W2579159570 hasLocation W25791595702 @default.
• W2579159570 hasOpenAccess W2579159570 @default.
• W2579159570 hasPrimaryLocation W25791595701 @default.
• W2579159570 hasRelatedWork W1597206381 @default.
• W2579159570 hasRelatedWork W1988619378 @default.
• W2579159570 hasRelatedWork W2026433544 @default.
• W2579159570 hasRelatedWork W2046181946 @default.
• W2579159570 hasRelatedWork W2047734296 @default.
• W2579159570 hasRelatedWork W2068682244 @default.
• W2579159570 hasRelatedWork W2099730382 @default.
• W2579159570 hasRelatedWork W2179024405 @default.
• W2579159570 hasRelatedWork W2800638941 @default.
• W2579159570 hasRelatedWork W4362612748 @default.
• W2579159570 hasVolume "55" @default.
• W2579159570 isParatext "false" @default.
• W2579159570 isRetracted "false" @default.

• next